Re: Wei Shen Tan, Aaron Prendergast, Charlotte Ackermann, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.003

Eur Urol. 2023 Feb;83(2):e56-e57. doi: 10.1016/j.eururo.2022.09.035. Epub 2022 Nov 10.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Clinical Trial, Phase II
  • Letter
  • Comment

MeSH terms

  • Adjuvants, Immunologic
  • Administration, Intravesical
  • Humans
  • Mitomycin
  • Non-Muscle Invasive Bladder Neoplasms*
  • Urinary Bladder Neoplasms* / drug therapy

Substances

  • Mitomycin
  • Adjuvants, Immunologic